Addition of Thalidomide (T) to Oral Melphalan/Prednisone (MP) in Patients with Multiple Myeloma: Initial Results of a Randomized Trial From the Turkish Myeloma Study Group.

Beksac, MeralHaznedar, RaufFiratli-Tuglular, TulinOzdogu, HakanAydogdu, IsmetKonuk, NahideSucak, Gulsan2024-08-042024-08-0420090006-4971https://hdl.handle.net/11616/10227751st Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2009 -- New Orleans, LA[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]Addition of Thalidomide (T) to Oral Melphalan/Prednisone (MP) in Patients with Multiple Myeloma: Initial Results of a Randomized Trial From the Turkish Myeloma Study Group.Conference Object11422746747WOS:000272725802248Q1